Termination of Pregnancy With Mifepristone and Misoprostol Versus Sulprostone

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Atrium Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Atrium Medical Center
ClinicalTrials.gov Identifier:
NCT00206193
First received: September 13, 2005
Last updated: October 29, 2007
Last verified: September 2005

September 13, 2005
October 29, 2007
Not Provided
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00206193 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Termination of Pregnancy With Mifepristone and Misoprostol Versus Sulprostone
Not Provided

The purpose of this study is to determine which medical treatment is the most effective to terminate a pregnancy.

Not Provided
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Not Provided
Not Provided
Abortion, Induced
  • Drug: mifepristone
  • Drug: misoprostol
  • Drug: sulprostone
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Pregnant women by whom a termination of pregnancy is desired.

Exclusion Criteria:

  • Women with liver/kidney disease
  • Women on long-term use of corticosteroids (> 6 months)
  • Cardiovascular problems
  • Therapy-resistant diabetic women
  • Therapy-resistant asthma/bronchitis
  • Thalassemia
  • Ulcerative colitis
  • Peptic ulcer disease
  • Glaucoma
  • Porphyria
  • Allergic reaction to prostaglandin or mifepristone
  • Women with a prior caesarian section or women with contractions at the start of the study
Female
18 Years and older
Not Provided
Contact: Suzanne HW Vonken, Dr. 003145-5766666 ext 466825 svonken@gmail.com
Contact: F Roumen, Dr. 003145-5766666 ext 466509
Netherlands
 
NCT00206193
TOP-protocol
Not Provided
Not Provided
Atrium Medical Center
Not Provided
Study Director: F Roumen, Dr. Atrium Medisch Centrum, Heerlen
Atrium Medical Center
September 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP